Akorn Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Akorn Inc.

Akorn Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

52,362.00

13,380.00

150,798.00

184,243.00

24,550.00

401,909

Depreciation, Depletion & Amortization

14,476.00

57,831.00

86,924.00

87,963.00

85,173.00

82,805

Other Funds

2,928.00

14,517.00

39,006.00

264,361

Funds from Operations

71,536.00

60,321.00

202,106.00

305,747.00

96,595.00

92,139

Changes in Working Capital

14,210.00

19,879.00

95,542.00

137,988.00

152,669.00

23,245

Net Operating Cash Flow

57,326.00

40,442.00

297,648.00

167,759.00

249,264.00

68,894

Capital Expenditures

11,642.00

38,807.00

31,769.00

78,888.00

95,370.00

Sale of Fixed Assets & Businesses

59,361.00

2,459.00

5,966.00

4,815.00

Net Investing Cash Flow

66,874.00

966,874.00

53,718.00

72,922.00

90,555.00

Issuance/Reduction of Debt, Net

3,032.00

931,586.00

19,014.00

205,128.00

Net Financing Cash Flow

3,118.00

963,116.00

31,908.00

240,333.00

7,594.00

Net Change in Cash

6,603.00

36,501.00

275,587.00

145,494.00

167,347.00

Free Cash Flow

45,684.00

10,543.00

269,714.00

92,821.00

154,094.00

Deferred Taxes & Investment Tax Credit

2,091.00

17,511.00

46,130.00

32,934.00

115,249.00

37,396

Net Assets from Acquisitions

55,482.00

987,428.00

24,408.00

Other Sources

250.00

Change in Capital Stock

3,222.00

17,013.00

11,916.00

35,205.00

7,594.00

Exchange Rate Effect

173.00

183.00

251.00

2.00

1,044.00

About Akorn

View Profile

Address	1925 West Field Court Lake Forest Illinois 60045 United States
Employees	-
Website	http://www.akorn.com
Updated	07/08/2019
Akorn, Inc. operates as a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays.